Patient’s Stage IV Cancer Vanishes During CIRM-Funded Clinical Trial
A testimonial from Tom Howing, whose stage IV metastatic cancer disappeared after treatment with a CIRM-funded gene-therapy developed by Forty-Seven Pharma. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 36480]